The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-methoxyphenyl)-4-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanamido)benzamide ID: ALA2314698
Cas Number: 869474-43-1
PubChem CID: 135566794
Product Number: W417934, Order Now?
Max Phase: Preclinical
Molecular Formula: C25H22N4O4
Molecular Weight: 442.48
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccccc1NC(=O)c1ccc(NC(=O)CCc2nc3ccccc3c(=O)[nH]2)cc1
Standard InChI: InChI=1S/C25H22N4O4/c1-33-21-9-5-4-8-20(21)28-24(31)16-10-12-17(13-11-16)26-23(30)15-14-22-27-19-7-3-2-6-18(19)25(32)29-22/h2-13H,14-15H2,1H3,(H,26,30)(H,28,31)(H,27,29,32)
Standard InChI Key: WWKKOAKRYQQEBT-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 36 0 0 0 0 0 0 0 0999 V2000
2.6441 -9.3935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6430 -10.2131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3510 -10.6220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3492 -8.9847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0579 -9.3899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0612 -10.2106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7697 -10.6157 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4793 -10.2048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4759 -9.3841 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7629 -8.9744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7585 -8.1573 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1881 -10.6114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1904 -11.4286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8992 -11.8353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9014 -12.6525 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6058 -11.4248 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6102 -13.0592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6101 -13.8768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3181 -14.2834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0256 -13.8728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0208 -13.0514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3122 -12.6485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7350 -14.2786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7383 -15.0957 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4410 -13.8671 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4477 -15.5015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4466 -16.3160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1551 -16.7217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8621 -16.3102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8562 -15.4888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1471 -15.0868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7393 -16.7254 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0311 -16.3176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 2 0
8 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
20 23 1 0
23 24 1 0
23 25 2 0
24 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 26 1 0
27 32 1 0
32 33 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 442.48Molecular Weight (Monoisotopic): 442.1641AlogP: 3.76#Rotatable Bonds: 7Polar Surface Area: 113.18Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.91CX Basic pKa: 5.40CX LogP: 2.97CX LogD: 2.98Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.40Np Likeness Score: -1.55
References 1. Bregman H, Gunaydin H, Gu Y, Schneider S, Wilson C, DiMauro EF, Huang X.. (2013) Discovery of a class of novel tankyrase inhibitors that bind to both the nicotinamide pocket and the induced pocket., 56 (3): [PMID:23316926 ] [10.1021/jm301607v ] 2. Hua Z, Bregman H, Buchanan JL, Chakka N, Guzman-Perez A, Gunaydin H, Huang X, Gu Y, Berry V, Liu J, Teffera Y, Huang L, Egge B, Emkey R, Mullady EL, Schneider S, Andrews PS, Acquaviva L, Dovey J, Mishra A, Newcomb J, Saffran D, Serafino R, Strathdee CA, Turci SM, Stanton M, Wilson C, Dimauro EF.. (2013) Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors., 56 (24): [PMID:24294969 ] [10.1021/jm401317z ] 3. Liu Z, Wang P, Wold EA, Song Q, Zhao C, Wang C, Zhou J.. (2021) Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer., 64 (8.0): [PMID:33822624 ] [10.1021/acs.jmedchem.0c01799 ]